Live feed
Filing
SC 13D
SC 13D0001193125-19-105171·COLUMN GROUP L P
Schedule 13D ownership disclosure
NGM BIOPHARMACEUTICALS INC
Security class unavailable · CUSIP: 62921N105
Event date: 2019-04-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 17.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-19-105171
- Form type
- SC 13D
- Filer
- COLUMN GROUP L P
- CIK
- CIK 1347769
- Filed
- Apr 12, 2019
- Reporting period
- Apr 03, 2019
- Description
- Schedule 13D beneficial ownership